Boxer Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
Boxer Capital Management's SNDX Position: Q4 2021 in Review
Boxer Capital Management sold out of Syndax Pharmaceuticals (SNDX) in Q4 2021, closing a stake of 2,287,782 shares — an estimated $43.7M sold.
Boxer Capital Management first reported a position in SNDX in Q1 2016 and held it in 20 quarters. The position peaked at $51.2M in Q1 2021. 132 funds tracked by Wall St. Rank hold SNDX as of Q4 2021.
- Boxer Capital Management reported no remaining Syndax Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Boxer Capital Management sold 2,287,782 Syndax Pharmaceuticals shares in Q4 2021, an estimated $43.7M.
- Boxer Capital Management first reported a position in Syndax Pharmaceuticals in Q1 2016 and held it in 20 quarters.
- Boxer Capital Management's Syndax Pharmaceuticals position peaked at $51.2M in Q1 2021.
- 132 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2021.
Based on Boxer Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.